Skip to main navigation Skip to search Skip to main content

Oxazolidinones as novel human CCR8 antagonists

  • Jian Jin
  • , Yonghui Wang
  • , Feng Wang
  • , Jeffery K. Kerns
  • , Victoria M. Vinader
  • , Ashley P. Hancock
  • , Matthew J. Lindon
  • , Graeme I. Stevenson
  • , Dwight M. Morrow
  • , Parvathi Rao
  • , Cuc Nguyen
  • , Victoria J. Barrett
  • , Chris Browning
  • , Guido Hartmann
  • , David P. Andrew
  • , Henry M. Sarau
  • , James J. Foley
  • , Anthony J. Jurewicz
  • , James A. Fornwald
  • , Andy J. Harker
  • Michael L. Moore, Ralph A. Rivero, Kristen E. Belmonte, Helen E. Connor

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

High-throughput screening of the corporate compound collection led to the discovery of a novel series of N-substituted-5-aryl-oxazolidinones as potent human CCR8 antagonists. The synthesis, structure-activity relationships, and optimization of the series that led to the identification of SB-649701 (1a), are described.

Original languageEnglish
Pages (from-to)1722-1725
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number6
DOIs
StatePublished - 15 Mar 2007
Externally publishedYes

Keywords

  • Antagonists
  • Asthma
  • CCR8
  • Chemokine receptors
  • HIV
  • N-substituted-5-aryl-oxazolidinones

Fingerprint

Dive into the research topics of 'Oxazolidinones as novel human CCR8 antagonists'. Together they form a unique fingerprint.

Cite this